South Korea · Delayed Price · Currency is KRW Kwang Dong Pharmaceutical Statistics
Total Valuation
KRX:009290 has a market cap or net worth of KRW 241.18 billion. The enterprise value is 354.55 billion.
| Market Cap | 241.18B |
| Enterprise Value | 354.55B |
Important Dates
The last earnings date was Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
KRX:009290 has 39.28 million shares outstanding. The number of shares has decreased by -1.64% in one year.
| Current Share Class | 39.28M |
| Shares Outstanding | 39.28M |
| Shares Change (YoY) | -1.64% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 12.95% |
| Owned by Institutions (%) | 25.50% |
| Float | 32.15M |
Valuation Ratios
The trailing PE ratio is 8.30.
| PE Ratio | 8.30 |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | 35.14 |
| P/OCF Ratio | 4.20 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.26, with an EV/FCF ratio of 51.66.
| EV / Earnings | 12.15 |
| EV / Sales | 0.22 |
| EV / EBITDA | 9.26 |
| EV / EBIT | 16.83 |
| EV / FCF | 51.66 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.41 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 6.76 |
| Debt / FCF | 41.98 |
| Interest Coverage | 2.28 |
Financial Efficiency
Return on equity (ROE) is 4.87% and return on invested capital (ROIC) is 1.73%.
| Return on Equity (ROE) | 4.87% |
| Return on Assets (ROA) | 1.32% |
| Return on Invested Capital (ROIC) | 1.73% |
| Return on Capital Employed (ROCE) | 3.51% |
| Revenue Per Employee | 1.60B |
| Profits Per Employee | 28.58M |
| Employee Count | 1,021 |
| Asset Turnover | 1.36 |
| Inventory Turnover | 6.59 |
Taxes
In the past 12 months, KRX:009290 has paid 10.18 billion in taxes.
| Income Tax | 10.18B |
| Effective Tax Rate | 25.09% |
Stock Price Statistics
The stock price has increased by +10.23% in the last 52 weeks. The beta is 0.18, so KRX:009290's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | +10.23% |
| 50-Day Moving Average | 5,858.60 |
| 200-Day Moving Average | 5,804.00 |
| Relative Strength Index (RSI) | 59.40 |
| Average Volume (20 Days) | 86,055 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:009290 had revenue of KRW 1.64 trillion and earned 29.18 billion in profits. Earnings per share was 739.89.
| Revenue | 1.64T |
| Gross Profit | 289.96B |
| Operating Income | 25.37B |
| Pretax Income | 40.57B |
| Net Income | 29.18B |
| EBITDA | 42.62B |
| EBIT | 25.37B |
| Earnings Per Share (EPS) | 739.89 |
Balance Sheet
The company has 214.40 billion in cash and 288.10 billion in debt, giving a net cash position of -73.70 billion or -1,876.22 per share.
| Cash & Cash Equivalents | 214.40B |
| Total Debt | 288.10B |
| Net Cash | -73.70B |
| Net Cash Per Share | -1,876.22 |
| Equity (Book Value) | 632.20B |
| Book Value Per Share | 15,084.49 |
| Working Capital | 206.25B |
Cash Flow
In the last 12 months, operating cash flow was 57.45 billion and capital expenditures -50.58 billion, giving a free cash flow of 6.86 billion.
| Operating Cash Flow | 57.45B |
| Capital Expenditures | -50.58B |
| Free Cash Flow | 6.86B |
| FCF Per Share | 174.73 |
Margins
Gross margin is 17.70%, with operating and profit margins of 1.55% and 1.78%.
| Gross Margin | 17.70% |
| Operating Margin | 1.55% |
| Pretax Margin | 2.48% |
| Profit Margin | 1.78% |
| EBITDA Margin | 2.60% |
| EBIT Margin | 1.55% |
| FCF Margin | 0.42% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.67%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 1.67% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 13.46% |
| Buyback Yield | 1.64% |
| Shareholder Yield | 3.32% |
| Earnings Yield | 12.10% |
| FCF Yield | 2.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 26, 1999. It was a forward split with a ratio of 5.
| Last Split Date | Apr 26, 1999 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
KRX:009290 has an Altman Z-Score of 2.46 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.46 |
| Piotroski F-Score | 5 |